ANTARES PHARMA, INC. Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2017 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Senior Vice Preside ... | Buy | P | 2.79 | 130,000 | 363,272 | 331,434 | 201.4 K to 331.4 K (+64.54 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Senior Vice Preside ... | Option Exercise | A | 2.66 | 217,725 | 579,149 | 217,725 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Senior Vice Preside ... | Grant | A | 2.66 | 101,434 | 269,814 | 201,434 | 100 K to 201.4 K (+101.43 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | SVP General Counsel ... | Option Exercise | A | 2.66 | 217,725 | 579,149 | 217,725 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | SVP General Counsel ... | Grant | A | 2.66 | 101,434 | 269,814 | 225,851 | 124.4 K to 225.9 K (+81.53 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | SVP General Counsel ... | Payment of Exercise | F | 2.57 | 16,633 | 42,747 | 124,417 | 141.1 K to 124.4 K (-11.79 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.66 | 725,751 | 1,930,498 | 725,751 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.66 | 338,115 | 899,386 | 1,175,637 | 1.5 M to 1.2 M (-22.34 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.57 | 38,034 | 97,747 | 837,522 | 875.6 K to 837.5 K (-4.34 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.51 | 3,390 | 8,509 | 875,556 | 878.9 K to 875.6 K (-0.39 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.51 | 14,903 | 37,407 | 878,946 | 893.8 K to 878.9 K (-1.67 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.37 | 1,763 | 4,178 | 893,849 | 895.6 K to 893.8 K (-0.20 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 0.00 | 5,612 | 0 | 895,612 | 890 K to 895.6 K (+0.63 %) |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.66 | 160,636 | 427,292 | 160,636 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 |